how many people in the us are taking glp 1 GLP-1 trends 2025: real-world data, patient outcomes & future therapies GLP-1 Survey: 37.5% of People

The world's first 90-day GLP program

And our mini size glp1 capsules eliminate unpleasant taste & odors white keeping active probiotics by delayed release technology, making glp-1 easy to incorporate into your daily routine

L-carnitine supplementation may complement semaglutide therapy, but timing, dosing, and individual metabolism matter

We published case reports and case series suggesting that these drugs may be beneficial for a large subset of patient population with #chronicillness.

The Lancet 2026

As with other complex diseases, the next era likely involves precision, combination therapypairing antiamyloid agents with treatments aimed at metabolic, inflammatory, vascular, and synaptic pathways